Characteristics of the metabolic risk factors in patients with cancers/precancers
| High BP (SBP≥140 and/or DBP≥90) | SBP<140 and/or DBP<90 | High RBS (RBS≥140) | RBS<140 | Overweight/obese (BMI≥25) | BMI<25 | Total | |
| OPMD | 169 (31.18) | 373 (68.82) | 73 (13.47) | 469 (86.53) | 202 (37.27) | 340 (62.73) | 542 (100) |
| Reference group (without OPMD/oral cancer) | 2074 (26.67) | 5689 (73.32) | 852 (10.91) | 6913 (89.07) | 3211 (41.43) | 4552 (58.72) | 7763 (100) |
| P value | 0.03 | 0.17 | 0.06 | ||||
| Oral cancers | 14 (29.79) | 33 (70.22) | 9 (19.15) | 38 (80.85) | 6 (12.77) | 41 (87.23) | 47 (100) |
| Reference group (without oral cancer/OPMD)* | 2074 (26.72) | 5689 (73.28) | 852 (10.98) | 6913 (89.05) | 3211 (41.36) | 4552 (58.6) | 7763 (100) |
| P value | 0.64 | 0.10 | <0.0001 | ||||
| Cervical precancerous lesions | 8 (28.67) | 22 (73.33) | 4 (13.33) | 26 (86.67) | 15 (50) | 15 (50) | 30 (100) |
| Reference group (without cervical precancer/cervical cancer) | 1735 (26.10) | 4913 (73.90) | 763 (11.48) | 5885 (88.52) | 2799 (42.10) | 3849 (57.90) | 6648 (100) |
| P value | 0.94 | 0.75 | 0.38 | ||||
| Cervical cancer | 13 (38.2) | 21 (61.8) | 4 (11.8) | 30 (88.3) | 16 (47.1) | 18 (52.9) | 34 (100) |
| Reference group (without cervical cancer/precancer)† | 1735 (26.10) | 4913 (73.90) | 763 (11.48) | 5885 (88.52) | 2799 (42.10) | 3849 (57.90) | 6648 (100) |
| P value | 0.11 | 0.96 | 0.56 | ||||
| Breast cancer | 26 (49.06) | 27 (50.9) | 12 (22.6) | 41 (77.36) | 28 (52.83) | 25 (47.17) | 53 (100) |
| Reference group‡ | 1730 (25.98) | 4929 (74.02) | 759 (11.40) | 5900 (88.60) | 2802 (42.08) | 3857 (57.92) | 6659 (100) |
| P value | <0.0001 | 0.01 | 0.11 | ||||
*Population without oral cancer or OPMD.
†Female population without cervical cancer or cervical precancer.
‡Female population without breast cancer.
BMI, body mass index; BP, blood pressure; DBP, diastolic blood pressure; OPMD, oral potentially malignant disease; RBS, random blood sugar; SBP, systolic blood pressure.